Tag: Competition

Displaying 61 - 80 of 1865 results.

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Sun Pharmaceutical Industries Ltd.’s $4 billion acquisition of Ranbaxy Laboratories Ltd. would likely be anticompetitive.
Texas-based energy company Par Petroleum Corporation will terminate its storage and throughput rights at a key gasoline terminal in Hawaii, to settle Federal Trade Commission charges that Par’s proposed $107 million acquisition of Koko’oha Investments, Inc.’s wholly-owned subsidiary Mid Pac...
From time to time, the Commission revises its rules of practice in the interest of fairness, flexibility and efficiency—in other words, to improve the process it relies on for its investigations, studies and adjudicative proceedings. For instance, in 2009, the Commission made...
Some will remember 1976 as the year of the nation’s bicentennial, but it was also the year that Congress gave the antitrust agencies an important tool to prevent harmful mergers before the harm occurs and before the assets and operations of the merging parties are joined in a way...
The Federal Trade Commission today adopted revisions to the agency’s Rules of Practice.
Recently, I appeared on a panel that discussed the Commission’s recent Section 5 cases.
There is still time to submit public comments on the FTC’s proposal to study the effectiveness of its remedial orders in merger cases. Fifteen years have passed since the Bureau’s previous Divestiture Study, which resulted in a number of important findings that caused the Commission...
Pharmaceutical companies Impax Laboratories Inc. and CorePharma, LLC have agreed to divest all of CorePharma’s rights and assets to generic pilocarpine tablets and generic ursodiol tablets, in order to settle  Federal Trade Commission charges that Impax’s proposed $700 million acquisition of...
Although FTC staff often rely on voluntary requests for information in the early stages of an investigation, the use of official subpoena and civil investigative demands authorized by the Commission is essential to uncover potential law violations, and when necessary, to pursue a law...
Following a public comment period, the Federal Trade Commission has approved an application from Community Health Systems to sell Riverview Regional Medical Center and its associated assets near Gadsden, Alabama.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Eli Lilly and Company’s acquisition of Novartis Animal Health would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved final orders settling charges in two separate cases alleging that the bylaws of the trade associations restrained competition.  
Yesterday, the Supreme Court affirmed the Fourth Circuit’s decision to uphold the FTC’s order against the North Carolina State Board of Dental Examiners In a tour-de-force opinion laying out the proper scope of the state action doctrine first articulated in Parker v.
Following a public comment period, the Federal Trade Commission has approved an application from the owners of Surgery Center Holdings, known as Surgery Partners to divest Symbion Holdings Corporation’s ownership interest in the Blue Springs Surgery Center in Orange City, Florida, to Dr. Mark W....
“Today, the Supreme Court affirmed the FTC's position in recognizing that a state may not give private market participants unsupervised authority to suppress competition even if they act through a formally designated ‘state agency’."
Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle charges that Novartis’s $16 billion acquisition of GlaxoSmithKline’s portfolio of cancer-treatment...

Pages